Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (1461-1470 of 1,553) with videos related to

Pageof 156
Sort By:
International Journal of Cancer|September 19, 2022
First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysisTianshu Liu, Yuxian Bai, Xiaoyan Lin, et al.
Nature Communications|January 29, 2021
LPA signaling acts as a cell-extrinsic mechanism to initiate cilia disassembly and promote neurogenesisHuai-Bin Hu, Zeng-Qing Song, Guang-Ping Song, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 11, 2024
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumorsJian Li, Ye Xu, Aimin Zang, et al.
Nature Medicine|May 22, 2024
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trialXiangyu Gao, Ke Ji, Yongning Jia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2026
Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal CancerChangsong Qi, Chang Liu, Jifang Gong, et al.
Military Medical Research|January 28, 2025
MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignanciesBu-Fu Tang, Wang-Ting Xu, Shi-Ji Fang, et al.
ACS Nano|May 22, 2012
Rapid transformation of protein-caged nanomaterials into microbubbles as bimodal imaging agentsCheng-An J Lin, Wen-Kai Chuang, Zih-Yun Huang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2020
Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)Li Ren, Dexiang Zhu, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2023
Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic CancerShukui Qin, Jin Li, Yuxian Bai, et al.
Nature Medicine|May 9, 2022
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim resultsChangsong Qi, Jifang Gong, Jian Li, et al.
Pageof 156

Showing results (1461-1470 of 1,553) with videos related to

Sort By:
Pageof 156
International Journal of Cancer|September 19, 2022
First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysisTianshu Liu, Yuxian Bai, Xiaoyan Lin, et al.
Nature Communications|January 29, 2021
LPA signaling acts as a cell-extrinsic mechanism to initiate cilia disassembly and promote neurogenesisHuai-Bin Hu, Zeng-Qing Song, Guang-Ping Song, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 11, 2024
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumorsJian Li, Ye Xu, Aimin Zang, et al.
Nature Medicine|May 22, 2024
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trialXiangyu Gao, Ke Ji, Yongning Jia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2026
Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal CancerChangsong Qi, Chang Liu, Jifang Gong, et al.
Military Medical Research|January 28, 2025
MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignanciesBu-Fu Tang, Wang-Ting Xu, Shi-Ji Fang, et al.
ACS Nano|May 22, 2012
Rapid transformation of protein-caged nanomaterials into microbubbles as bimodal imaging agentsCheng-An J Lin, Wen-Kai Chuang, Zih-Yun Huang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2020
Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)Li Ren, Dexiang Zhu, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2023
Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic CancerShukui Qin, Jin Li, Yuxian Bai, et al.
Nature Medicine|May 9, 2022
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim resultsChangsong Qi, Jifang Gong, Jian Li, et al.
Pageof 156